#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>19 Units or less: Negative 20-39 Units: Weak positive 40-59 Units: Moderate positive 60 Units or Greater: Strong positive
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
86200
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
ACPA Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anti-CCP Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anti-Citrullinated Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anti-Citrullinated Protein/Peptide Antibody (ACPA) (Cyclic Citrullinated Peptide (CCP) Antibody, IgG)
, Anti-Citrulline Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), AntiCCP Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anticitrullinated Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anticitrullinated Protein/Peptide Antibody (ACPA) (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anticitrulline Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Anticyclic Citrullinated Peptide (CCP) Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), CCP3 Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Citrullinated Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Citrullinated Protein/Peptide Antibody (ACPA) (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Citrulline Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG), Soft-CCP (Cyclic Citrullinated Peptide (CCP) Antibody, IgG) |
*ExistCrossReferences>